These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9638277)

  • 21. Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans) against the multidrug-resistant strain of Plasmodium yoelii nigeriensis (MDR) in vivo.
    Tripathi R; Jefford CW; Dutta GP
    Parasitology; 2006 Jul; 133(Pt 1):1-9. PubMed ID: 16764736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.
    Wang R; Charoenvit Y; Daly TM; Long CA; Corradin G; Hoffman SL
    Immunol Lett; 1996 Nov; 53(2-3):83-93. PubMed ID: 9024983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
    Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.
    Siddiqi NJ; Alhomida AS
    In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rodent malaria prophylaxis by transdermal delivery of primaquine.
    Mayorga P; Miltgen F; Coquelin F; Couarraze G
    Int J Parasitol; 1998 Aug; 28(8):1283-5. PubMed ID: 9762576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Cymbopogon giganteus and Enantia chrantha against chloroquine resistant Plasmodium yoelii nigeriensis.
    Kimbi HK; Fagbenro-Beyioku AF
    East Afr Med J; 1996 Oct; 73(10):636-7. PubMed ID: 8997841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
    Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
    In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.
    Labaied M; Harupa A; Dumpit RF; Coppens I; Mikolajczak SA; Kappe SH
    Infect Immun; 2007 Aug; 75(8):3758-68. PubMed ID: 17517871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of azithromycin as a causal prophylactic agent against murine malaria.
    Andersen SL; Ager AL; McGreevy P; Schuster BG; Ellis W; Berman J
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1862-3. PubMed ID: 7986022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro.
    Basco LK; Ringwald P; Le Bras J
    Ann Trop Med Parasitol; 1991 Apr; 85(2):223-8. PubMed ID: 1686703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites.
    Putrianti ED; Silvie O; Kordes M; Borrmann S; Matuschewski K
    J Infect Dis; 2009 Mar; 199(6):899-903. PubMed ID: 19434915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605.
    Peters W; Robinson BL; Milhous WK
    Ann Trop Med Parasitol; 1993 Dec; 87(6):547-52. PubMed ID: 8122915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum of the antimalarial activity of a new macrolide antibiotic midecamycin in mice and monkeys.
    Puri SK; Dutta GP
    Chemotherapy; 1989; 35(3):187-92. PubMed ID: 2766859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haem polymerase as a novel target of antimalarial action of cyproheptadine.
    Agrawal R; Tripathi R; Tekwani BL; Jain SK; Dutta GP; Shukla OP
    Biochem Pharmacol; 2002 Nov; 64(9):1399-406. PubMed ID: 12392821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single dose curative and prophylactic efficacy of antimalarial drugs against multi-resistant Plasmodium yoelii nigeriensis.
    Shukla B; Dutta GP
    J Commun Dis; 1988 Sep; 20(3):175-84. PubMed ID: 3256563
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of autacoid inhibitors and of an antagonist on malaria infection in mice.
    Iwalewa EO; Agbani EO
    Braz J Med Biol Res; 2004 Aug; 37(8):1199-204. PubMed ID: 15273821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
    Charoenvit Y; Mellouk S; Cole C; Bechara R; Leef MF; Sedegah M; Yuan LF; Robey FA; Beaudoin RL; Hoffman SL
    J Immunol; 1991 Feb; 146(3):1020-5. PubMed ID: 1988490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of chloroquine resistance in Plasmodium yoelii nigeriensis.
    Kimbi HK; Fagbenro-Beyioku AF
    East Afr Med J; 1996 Oct; 73(10):634-5. PubMed ID: 8997840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.